Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02323399 · ClinicalTrials.gov registry record · Phase 4
Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV
A Phase 4 study of Hypotension, sponsored by West-Ward Pharmaceutical.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 10
- Study locations
NCT02323399: Recruiting Phase 4 study of Hypotension, sponsored by West-Ward Pharmaceutical.
NCT02323399 is a Phase 4 study of Hypotension that is actively recruiting participants, run by West-Ward Pharmaceutical. The registered enrollment target is 100 participants, above the 72-participant average among 12 other Hypotension trials with a reported enrollment target (39% higher). The trial reports 10 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02323399, a Phase 4 study of Hypotension, is actively recruiting participants, sponsored by West-Ward Pharmaceutical.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 10
- Study locations
Study Summary
The primary objective of this study is to evaluate the dose effect of Phenylephrine Hydrochloride Injection on the treatment of clinically relevant decreased blood pressure in the pediatric population, ≥12 to 16 year old patients undergoing general and neuraxial anesthesia. The secondary objectives are to describe changes in blood pressure and heart rate, time to onset and to maximal response, and the duration of response; to assess the safety of the product in this population; and to characterize the pharmacokinetics of phenylephrine hydrochloride.
Conditions Studied
Interventions
- DRUG Phenylephrine
Study Locations (10)
Delaware
- Alfred I. DuPont Hospital for Children - Wilmington
District of Columbia
- Children's National Medical Center - Washington D.C.
Florida
- Jackson Memorial Hospital - Miami
Georgia
- Children's Healthcare of Atlanta at Egleston - Atlanta
Mississippi
- University of Mississippi Medical Center - Jackson
New York
- Stony Brook Medicine - Stony Brook
Ohio
- Cleveland Clinic - Cleveland
Texas
- Children's Medical Center of Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-02 |
| Est. Completion | 2024-12 |
| Phase | Phase 4 |
What NCT02323399 shows while recruiting
NCT02323399 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 72-participant average among 12 other Hypotension trials with a reported enrollment target (39% higher).
The record links to 1 condition, with Hypotension appearing as the primary indexed condition, and to 1 intervention - of which Phenylephrine is the first listed.
NCT02323399 lists 10 locations in 10 states (Delaware, District of Columbia, Florida).
Frequently Asked Questions
What is clinical trial NCT02323399 about?
NCT02323399 is a clinical study titled "Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV". The primary objective of this study is to evaluate the dose effect of Phenylephrine Hydrochloride Injection on the treatment of clinically relevant decreased blood pressure in the pediatric population, ≥12 to 16 year old patients undergoing general and neuraxial anesthesia. The secondary objectives...
What is the current status of trial NCT02323399?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2015-02. Estimated completion is 2024-12.
What conditions does trial NCT02323399 study?
This clinical trial studies the following conditions: Hypotension.
What interventions are being tested in trial NCT02323399?
The interventions under investigation include: Phenylephrine (DRUG).
Who is sponsoring clinical trial NCT02323399?
This trial is sponsored by West-Ward Pharmaceutical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02323399 being conducted?
This trial has 10 study locations across Delaware, District of Columbia, Florida, Georgia, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypotension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02323399's enrollment target sits among peer trials
100 4th of 12 higher than 9 of 12 other Hypotension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypotension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Orthostatic Hypotension in SCI
RECRUITING · Phase 4
-
Evaluating Fluid Strategies in Thoracic Surgery Patients Utilizing a Goal Directed Approach
COMPLETED · Phase 4
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
-
Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)
RECRUITING · NA
-
TSCS for Acute SCI
RECRUITING · NA
-
Noninvasive Continuous BP Monitoring in Newborns Based on Pulsatile Signal Morphological Features Using NIRS
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia